Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inosine in early Parkinson's disease
NCT02642393Phase 3Completed
- Start
- Jun 2016
- Primary completion
- Jun 2019
- Countries
- 2
01
Overview
A Phase 3 trial of inosine in Parkinson's disease (PD). Started Jun 2016; status: completed.
02
Drugs
inosine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT02642393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02642393.